These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9951925)

  • 1. Transient spontaneous regression of hepatocellular carcinoma.
    Magalotti D; Gueli C; Zoli M
    Hepatogastroenterology; 1998; 45(24):2369-71. PubMed ID: 9951925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regression of hepatocellular carcinoma.
    Kondo S; Okusaka T; Ueno H; Ikeda M; Morizane C
    Int J Clin Oncol; 2006 Oct; 11(5):407-11. PubMed ID: 17058140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of hepatocellular carcinoma.
    Grossmann M; Hoermann R; Weiss M; Jauch KW; Oertel H; Staebler A; Mann K; Engelhardt D
    Am J Gastroenterol; 1995 Sep; 90(9):1500-3. PubMed ID: 7544955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of hepatocellular carcinoma in man.
    Desai HN
    S Afr Med J; 1976 Sep; 50(41):1611-3. PubMed ID: 62408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 7. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
    Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
    BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
    Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
    Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemoperitoneum supporting difficult diagnosis of diffuse hepatocarcinoma in liver cirrhosis].
    Vignoli A; Cioni G; Sardini C; Tincani E; Cristani A; Ventura E
    Recenti Prog Med; 1994 Apr; 85(4):235-7. PubMed ID: 7517061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
    Llovet JM
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):29-35. PubMed ID: 16431301
    [No Abstract]   [Full Text] [Related]  

  • 11. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).
    Trevisani F; De Notariis S; Rapaccini G; Farinati F; Benvegnù L; Zoli M; Grazi GL; Del PP; Di N; Bernardi M;
    Am J Gastroenterol; 2002 Mar; 97(3):734-44. PubMed ID: 11922571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P; Fusaro A; Daziano E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
    Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of sonography in diagnosing hepatocellular carcinoma.
    Tarantino G
    AJR Am J Roentgenol; 2007 May; 188(5):W494; author reply W495. PubMed ID: 17449752
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
    Maringhini A; Cottone M; Sciarrino E; Marcenò MP; La Seta F; Rinaldi F; Pagliaro L
    Cancer; 1984 Dec; 54(12):2924-6. PubMed ID: 6208995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
    Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should we screen for hepatocellular carcinoma?].
    Trinchet JC; Ganne-Carrié N
    Gastroenterol Clin Biol; 2006; 30(6-7):880-6. PubMed ID: 16885873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.